-
Originally Posted by Paint it Black
http://nzx-prod-s7fsd7f98s.s3-websit...147/417397.pdf
So the quarterly is attached. Good updates thanks NTL showing good work but unfortunately fairly predictable re DOC delays and the likelihood of another capital raise. At least DOC acknowledge their processing of a straight forward access approval (which is basically a renewal) is unacceptable and undertake to provide a decision in June, The processing route decision will go to the Board in the near future with the possible use of a modular plant. Whether this is a concentrator or full processor is unclear.
Much more clarity in this report which is good to see.
I like the debt facility and it appears like the DOC approval is all but time.
Interesting that they couldn't come to terms on treatment of the concentrate. As mentioned, for many existing operations the small tonnage could be more hassle than its worth.
Hopefully you find my posts helpful, but in no way should they be construed as advice. Make your own decision.
-
IMO I see despite DOC's best endeavours to to frustrate the approval process that the gold price has risen 35 % so thanks for the help and Im sure that with the pending possible C R it will be fully accepted.
-
What numbers/amount are shareholders picking for the capital raise requirements to carry them over until the cashflow covers outgoings?
-
Member
Originally Posted by Toddy
What numbers/amount are shareholders picking for the capital raise requirements to carry them over until the cashflow covers outgoings?
My stab is. Shares issued 500 million.
Rights offer is 2 for 3 @ 2.0c and there is a 25% take up = $1.67 million. This assumes DOC approval in place and processing route established to make the 2.0c attractive.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks